News

15 June 2017

EDUFLUVAC workshop: “Four years of European research on the development of universal influenza vaccines: what have we learnt, and how can we move forward?”

The third and last EDUFLUVAC workshop focusing on the latest achievement in Europe towards the development of a new generation of improved, long lasting and broadly protective influenza vaccines, successfully took place on 12-13 June at the House of Dutch Provinces, Brussels, Belgium. This workshop was organised in close collaboration with two other European Union (EU)-funded consortia, UNISEC and FLUTCORE.

18 April 2017

The meeting report from the EDUFLUVAC workshop on “Immunoassay standardisation for universal influenza vaccines” is now online.

A meeting report summarising the outcome of the EDUFLUVAC workshop on “Immunoassay standardisation for universal influenza vaccines” was recently published on Influenza and Other Respiratory Viruses journal.

 

09 December 2016

NIBSC makes new influenza reagent available

The following influenza reagents are now available on the NIBSC website:

Influenza Virus Infectious X-283A 42420 ExE1

Influenza Virus Infectious X-285A 42440 ExE1

Influenza Virus Infectious X-285 42430 ExE1

15 September 2016

VAC2VAC project website goes live

VAC2VAC is a wide ranging collaborative research project funded by IMI2 which aims to develop and validate quality testing approaches for both human and veterinary vaccines using non animal methods.  

The initiative  that  started  on  1  March 2016 aims  to  provide  the  data  to  support  the ‘Consistency Approach’ for quality control of established vaccines.  More information on the project and on the participants can now be found under the following link: www.vac2vac.eu.

09 September 2016

EVI Annual Report 2015 now available

The EVI 2015 Annual Report provides a detailed insight into all of EVI's activities, projects, important meetings etc.  We hope you will find it not only enlightening, but interesting reading.

06 July 2016

EDUFLUVAC workshop on experimental animal models for universal influenza vaccines

The second EDUFLUVAC workshop on experimental animal models for universal influenza vaccines took place on 23-24 June 2016 at the Biomedical Primate Research Centre, Rijswijk, The Netherlands.  The workshop was organised by EDUFLUVAC, EU - Framework programme 7 funded project with the financial support of Sanofi Pasteur and Viroclinics.

23 June 2016

The following products are now available on the NIBSC website:

The following products are now available on the The National Institute for Biological Standards and Control (NIBSC) website:

Influenza Virus Infectious NIBRG-306 ( Influenza Reagent )

23-06-2016 01:00 AM BST

17 June 2016

EVI moves to new address

As of 15 June 2016 EVI is domiciled at:

European Vaccine Initiative
UniversitätsKlinikum Heidelberg
Vossstrasse 2, Geb. 4040
69115 Heidelberg, Germany

14 June 2016

VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2)

European public and private organisations are collaborating in VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2) to develop and validate quality testing approaches for both human and veterinary vaccines using non-animal methods.

20 May 2016

The following products are now available on the NIBSC website

The following products are now available on the The National Institute for Biological Standards and Control (NIBSC) website:

Influenza Virus Infectious NYMC BX-35 41950 E11 (Influenza Reagent)
19-05-2016 01:00 AM BST

15/300